C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2002
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	CA2449942A1 Characterising polypeptides
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264825A1 Beta-Hydroxyalkylpicoliniumsalts
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263731A1 Method for producing 5-aryl nicotinaldehydes
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP1058678B1 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
12/11/2002	EP0966441B1 Process for preparing 2-hydroxy-6-trifluoromethylpyridine
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0920456B1 Phosgenated oxime resins and their preparation
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/11/2002	EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002	CN1384870A Method of bleaching stained fabrics
12/11/2002	CN1384869A Method of pretreating and bleaching stained fabrics
12/11/2002	CN1384837A Ligand and complex for catalytically bleaching substrate
12/11/2002	CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/11/2002	CN1095692C Halogenation catalyst
12/10/2002	US6492562 Invention also relates to novel intermediates and the resulting modified polyketides and antibiotics.
12/10/2002	US6492539 Preparation of preparing substituted indanones
12/10/2002	US6492524 Process for the synthesis of an aryl pyridine base using a zeolite catalyst
12/10/2002	US6492519 Chemical intermediate for antihistamine
12/10/2002	US6492502 Reduction of a quaternary ammonium containing nitro compound, to form an intermediate, oxidizing to give azo compound; useful for dyeing hair
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492405 Compounds containing sulfhydryl, disulfide, or group(s) capable of being converted in-vivo to a sulfhydryl group, and at least one nitrate group; use as substitutes for existing tolerance-inducing nitric oxide donors
12/10/2002	US6492399 Pharmaceutical compositions and methods for use
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492363 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
12/10/2002	US6492293 Polymerisation catalyst
12/10/2002	US6491989 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures
12/10/2002	CA2109934C Substituted indoles as anti-aids pharmaceuticals
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002097393A2 Cleavable surfactants and methods of use thereof
12/05/2002	WO2002096901A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/05/2002	WO2002096882A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096878A1 A short synthesis of pyridine-based pharmaceutical intermediates with sulfur-containing groups at the 2- and 3-positions
12/05/2002	WO2002096877A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096421A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2002064547A3 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
12/05/2002	WO2002011707A3 Drugs for incontinence
12/05/2002	US20020183517 Reacting dihydric alcohol characterized by four to six carbons, preferably 1,5-pentanediol, with excess ammonia in presence of ZSM-5 catalyst modified with nickel, copper or cobalt
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	US20020183365 Therapy or ameliorating an indication of the invention in an animal, including a human, comprising administering heteroaryl compond
12/05/2002	US20020183362 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002	US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002	US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
12/05/2002	US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002	DE10127041A1 New glycine N-(1-biphenyl-4-yl-2-substituted-ethyl)-amides, are integrin receptor inhibitors useful for treating e.g. angiogenic, cardiovascular, inflammatory and osteolytic or tumor diseases
12/05/2002	DE10125567A1 New N-aroyl-N'-(carbamoyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibiting hypoglycemic agents, especially useful for treating type II diabetes
12/05/2002	CA2448899A1 A short synthesis of pyridine-based pharmaceutical intermediates with sulfur-containing groups at the 2- and 3-positions
12/05/2002	CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	CA2445647A1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/04/2002	EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261338A1 Compositions and methods for treatment of epilepsy
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261327A2 Adenosine receptor modulators
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	CN1383425A Uracil substituted phenyl sulfamoyl carboxamides
12/04/2002	CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/03/2002	US6489497 Manufacture of α-olefins
12/03/2002	US6489485 Para-amine substituted phenylamide glucokinase activators
12/03/2002	US6489483 Reacting acetyl-substituted pyridine derivative with 3-aminoacrolein, reacting reaction product with ammonia or ammonium salt
12/03/2002	US6489481 Compounds used for treatment and/or prevention of neuronal apoptosis and/or excitotoxicity related neurological disorders

1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 633